4.6 Article

The Increasing Issue of Vancomycin-Resistant Enterococci and the Bacteriocin Solution

Journal

PROBIOTICS AND ANTIMICROBIAL PROTEINS
Volume 12, Issue 3, Pages 1203-1217

Publisher

SPRINGER
DOI: 10.1007/s12602-019-09618-6

Keywords

Enterococcus faecium; Enterococcus faecalis; VRE; Antibiotic resistance; Virulence; Bacteriocin

Funding

  1. Research Council of Norway [275190, 273646]
  2. Bio-based Industries Joint Undertaking under the European Union [790507]
  3. H2020 Societal Challenges Programme [790507] Funding Source: H2020 Societal Challenges Programme

Ask authors/readers for more resources

Enterococci are commensals of human and other animals' gastrointestinal tracts. Only making up a small part of the microbiota, they have not played a significant role in research, until the 1980s. Although the exact year is variable according to different geographical areas, this was the decade when vancomycin-resistant enterococci (VRE) were discovered and since then their role as causative agents of human infections has increased. Enterococcus faecium is on the WHO's list of bacteria for which new antibiotics are urgently needed, and with no new antibiotics in development, the situation is desperate. In this review, different aspects of VRE are outlined, including the mortality caused by VRE, antibiotic resistance profiles, animal-modeling efforts, and virulence. In addition, the limitations of current antibiotic treatments for VRE and prospective new treatments, such as bacteriocins, are reviewed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available